Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Blueprint Medi Cm ST (BPMC)

80.68 -3.4 (-4.04%)

05-23 16:00

Open:

83.94

Pre. Close:

84.08

High:

85.395

Low:

80.44

Volume:

229,203

Market Cap:

3537M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

85.439 - 85.875

85.875 - 86.21

Low:

79.461 - 79.903

79.903 - 80.241

Close:

79.986 - 80.721

80.721 - 81.285

Technical analysis  (as of: 2018-05-23 4:25:32 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 96.39     One year: 101.30

Support:

Support1: 75.73    Support2: 63.01

Resistance:

Resistance1: 82.53    Resistance2: 86.73

Pivot:

80.88

Moving Averages:

MA(5): 82.25     MA(20): 80.67

MA(100): 85.51     MA(250): 69.27

MACD:

MACD(12,26): -0.99     Signal(12,26,9): -1.67

%K %D:

%K(14,3): 62.47     %D(3): 63.09

RSI:

RSI(14): 46.50

52-Week:

High: 109  Low: 34.38  Change(%): 110.3

Average Vol(K):

3-Month: 44476  10-Days 55401

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
BPMC has closed above bottom band by 47.9%. Bollinger Bands are 40.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to BPMC's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-22T12:03:38-04:00
Core Biotech Buys #16: Taking Advantage Of Weakness To Add To Conviction Ideas

2018-05-17T12:21:47-04:00
Healthcare - Top 5 Gainers / Losers as of 12:20 AM (05/17/2018)

2018-05-17T09:00:00-04:00
Blueprint Medicines Announces Data Presentations at Upcoming ASCO and EHA Meetings Supporting Plans for Rapid Development of Avapritinib in Patients with Gastrointestinal Stromal Tumors and Systemic Mastocytosis

2018-05-17T07:57:35-04:00
Loxo's RET candidate LOXO-292 shows treatment effect in early-stage study, but still lags Blueprint's BLU-667

2018-05-17T01:52:55-04:00
Institutional Top Ideas Series: Opaleye Management

2018-05-16T17:52:08-04:00
Loxo Oncology +18% as cancer drug shows promise in early trial

2018-05-14T11:37:23-04:00
JF's Core Biotech Buys #15: Removal Of A Key Overhang, Buying Weakness In I-O, Updates And Adding To 2 Positions

2018-05-09T05:37:44-04:00
Pushing Preclinical: Wave Of Early-Stage Biotech IPOs Tests Investor Risk Appetite

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

43.84

Shares Float (M)

43.23

% Held by Insiders

1.40

% Held by Institutions

99.00

Shares Short (K)

1979

Shares Short Prior Month (K)

1880

Stock Financials

EPS

-4.340

EPS Est. Current Year

-3.660

EPS Est. Next Year

-4.410

EPS Est. Next Quarter

-1.050

Forward EPS

-5.671

Book Value (p.s.)

5.840

PEG Ratio

Profit Margin

Operating Margin

-705.90

Return on Assets (ttm)

-38.5

Return on Equity (ttm)

-46.5

Qtrly Rev. Growth

-78.8

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.602

Qtrly Earnings Growth

Operating Cash Flow (M)

-119.86

Levered Free Cash Flow (M)

-86.55

atoplab.com

Valuation

P/E

-18.59

P/E Growth Ratio

-0.04

P/BV

13.82

P/S

6205282816.00

P/CF

-29.51

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.